Approaches to Gradual Dose Reduction of Chronic Off-Label Antipsychotics Used for Behavioral and Psychological Symptoms of Dementia

Author： Tjia Jennifer   Reidenberg Marcus M.   Hunnicutt Jacob N.   Paice Kelli   Donovan Jennifer L.   Kanaan Abir   Briesacher Becky A.   Lapane Kate L.  

Publisher： American Society of Consultant Pharmacists

ISSN： 0888-5109

Source： The Consultant Pharmacist, Vol.30, Iss.10, 2015-10, pp. : 599-611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antipsychotics for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)

By  

Current Neuropharmacology, Vol. 6, Iss. 2, 2008-06 ,pp. : 117-124

Bentham Science Publishers

Access to resources Recommend Favorite

Atypical antipsychotics "widely used off-label", despite warnings

By  

Reactions Weekly, Vol. 1, Iss. 1302, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Atypical antipsychotics "widely used off-label", despite warnings

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 604, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality

By Ballard Clive   Creese Byron   Corbett Anne   Aarsland Dag  

Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. : 35-43

Informa Healthcare

Access to resources Recommend Favorite

Rising off-label use of antipsychotics a concern in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 621, 2011-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite